| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919736 | Radiotherapy and Oncology | 2011 | 5 Pages |
Abstract
Loss of E-cadherin and gain of vimentin may be associated with enhanced migration of tumour cells, leading to higher metastatic risk of HNSCC patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Monique M. Nijkamp, Paul N. Span, Ilse J. Hoogsteen, Albert J. van der Kogel, Johannes H.A.M. Kaanders, Johan Bussink,